The cyclic GMP‑AMP synthase–stimulator of interferon genes (cGAS‑STING) signaling axis functions as a central DNA sensor in mammalian innate immunity. By detecting cytosolic or otherwise abnormal DNA, this pathway initiates immune signaling cascades that contribute to antiviral defenses and help maintain tissue homeostasis. The pathway's activation leads to downstream immune effector responses, including induction of type I interferon and other innate immune mediators, which together limit pathogen spread and coordinate subsequent adaptive responses.
cGAS recognizes aberrant DNA in the cytosol and catalyzes production of second‑messenger cyclic dinucleotides that engage STING. STING activation then propagates signaling events that culminate in transcriptional programs associated with antiviral innate immunity. Within this framework, the cGAS‑STING axis senses non‑self or mislocalized self DNA and translates that detection into effector molecules critical for resisting microbial invasion and preserving cellular and tissue equilibrium.
The reviewed article emphasizes that cGAS‑STING has a dual role in cancer biology. On one hand, its activation can suppress oncogenesis by detecting viral or damaged DNA, inducing interferon responses and other antiviral mechanisms that curtail viral-mediated transformation. On the other hand, under certain circumstances the pathway can contribute to tumor progression. This context dependence means that cGAS‑STING signaling may act as a tumor suppressor in some settings while paradoxically promoting malignancy in others, depending on cell type, microenvironmental factors, and the nature of the initiating insult.
Oncogenic viruses cause cellular transformation through multiple mechanisms and interact with the host innate immune system, including the cGAS‑STING pathway. The manuscript reviews evidence that viruses associated with human tumors can activate cGAS‑STING, which may lead to inhibition of viral replication and reduced risk of malignant progression. Simultaneously, certain virus–host interactions exploit or dysregulate cGAS‑STING signaling to favor persistent infection or to create a pro‑tumorigenic environment, thereby facilitating the occurrence or advancement of related cancers. The review frames these interactions as bidirectional: antiviral sensing that defends against carcinogenesis, and viral strategies or consequences of signaling that can paradoxically support tumor development.
Recognizing the pathway's central role in antiviral immunity and cancer, the reviewed manuscript summarizes classes of molecules described as agonists or inhibitors of cGAS‑STING. These agents act at different steps of the activation mechanism to either boost innate immune responses (agonists) or to limit potentially deleterious chronic signaling (inhibitors). Such modulation has potential therapeutic implications for treating virus‑associated malignancies, enhancing antiviral immunity, or mitigating inflammation‑driven tumor promotion.
Note: the abstract excerpt indicates that the article summarizes agonists and inhibitors but does not list specific agents or clinical data in the provided text. For details on particular compounds, mechanisms of action, and preclinical or clinical evidence, refer to the full article.
The cGAS‑STING pathway is a pivotal mediator of innate immunity that impacts the host response to oncogenic viruses and the biology of virus‑associated cancers. Its dual role—both protective and potentially tumor‑promoting—highlights the need for nuanced understanding when considering therapeutic strategies. Modulators of cGAS‑STING signaling (both agonists and inhibitors) represent promising approaches for manipulating host immunity in the context of viral oncogenesis, but benefit versus risk will depend on disease context, timing, and mode of intervention.
The abstract provided here summarizes the scope and principal themes of the review but does not include granular experimental findings, lists of specific agonists or inhibitors, or detailed mechanistic data. Those items are reported in the full manuscript and reference list cited by the authors.
References cited in the source abstract include reviews and primary studies on viral activation and evasion of innate immunity, regulation of cGAS‑STING signaling, alternative STING signaling effectors, and links between mitochondrial DNA stress and antiviral priming. For clinicians and researchers, key takeaways are the centrality of cGAS‑STING in detecting oncogenic viral DNA, the pathway's context‑dependent effects on tumorigenesis, and the translational interest in pathway modulation for therapy.